Sansiri

SUNDAY, SEPTEMBER 01, 2013
Sansiri

One step back for sustainable steps forward After a feeble 1H13 showing, SIRI has sent a clear message by its determined efforts to streamline its operations, especially SG&A. Emphasis is more on margins, efficiency and ROE. We foresee a sequential rise

 
 
 
We cut our FY13-15 EPS by 5-8% (on 
concerns about transfers and SG&A) 
and our target price, now based on 
11x CY14 P/E, 1.5 s.d. above the 
6-year mean (given short-term
growth slowdown due to streamlined
operations and reversal of fund flows
from TIP markets) vs. 14x CY14 P/E 
previously. Still, its valuation is cheap 
with an attractive yield of 8% and 
solid catalysts (big jump in 4Q13 
earnings). Reiterate Outperform.
What Happened
Although SIRI’s FY13 transfer target 
was 80% locked in by backlog, SIRI
admitted that it will be challenge to 
fill the remaining 20% gap by the sale 
of finished inventories and new sales 
of SDH/TH with a short cash 
turnaround cycle given the softer
economic outlook. Still, management 
retains its target and will be more 
focused on streamlining its 
operational expenses, i.e. more 
effective SG&A control (e.g. adopting 
more pooling marketing expenses and
below-the-line ads, scaling down sale 
office, etc), to boost the bottomline.
What We Think
Despite the disappointing 1H13 
results, we anticipate a 2H13 earnings 
recovery for SIRI. We are encouraged
that SIRI has acknowledged its high 
SG&A spending and has started 
tackling the issue more seriously 
following its 1Q13 net loss. However, 
accounting issues surrounding 
amortisation expenses at its sales
offices for condo projects that were 
presold exceptionally quickly in 1Q13 
backfired on its 2Q13 earnings. As the 
take-up rates of the remaining 
presold projects normalised from 
2Q13 onwards, we believe it was a 
one-off effect. We expect 2H13 to pick 
up and 4Q13 to be the peak with 
substantial condo transfers, 
improving gross margins and a lower 
SG&A ratio. FY14 is promising with 
our sale revenue 50% secured by 
backlog with a rejection rate of 5-7%.
What You Should Do
Buy on weakness. Downside risk is 
limited given drastic consensus 
downgrades while the outlook is set to 
brighten. The risk-reward trade-off at 
this point is compelling, in our view.